Literature DB >> 32692914

Effects of Single α-to-β Residue Replacements on Recognition of an Extended Segment in a Viral Fusion Protein.

Victor K Outlaw1, Dale F Kreitler1, Debora Stelitano2,3,4, Matteo Porotto2,3,4, Anne Moscona2,3,5,6, Samuel H Gellman1.   

Abstract

Partial replacement of α-amino acid residues with β-amino acid residues has been established as a strategy for preserving target-engagement by helix-forming polypeptides while altering other properties. The impact of β-residue incorporation within polypeptides that adopt less regular conformations, however, has received less attention. The C-terminal heptad repeat (HRC) domains of fusion glycoproteins from pathogenic paramyxoviruses contain a segment that must adopt an extended conformation in order to coassemble with the N-terminal heptad repeat (HRN) domain in the postfusion state and drive a merger of the viral envelope with a target cell membrane. Here, we examine the impact of single α-to-β substitutions within this extended N-terminal segment of an engineered HRC peptide designated VIQKI. Stabilities of hexameric coassemblies formed with the native human parainfluenza virus 3 (HPIV3) HRN have been evaluated, the structures of five coassemblies have been determined, and antiviral efficacies have been measured. Many sites within the extended segment show functional tolerance of α-to-β substitution. These results offer a basis for future development of paramyxovirus infection inhibitors with novel biological activity profiles, possibly including resistance to proteolysis.

Entities:  

Keywords:  HPIV3; entry inhibitor; fusion glycoprotein; viral entry; α/β-peptide; β-amino acid

Mesh:

Substances:

Year:  2020        PMID: 32692914      PMCID: PMC8019249          DOI: 10.1021/acsinfecdis.0c00385

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  39 in total

Review 1.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules.

Authors:  Valeria Azzarito; Kérya Long; Natasha S Murphy; Andrew J Wilson
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

2.  Capping and alpha-helix stability.

Authors:  L Serrano; A R Fersht
Journal:  Nature       Date:  1989-11-16       Impact factor: 49.962

3.  T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo.

Authors:  Andrew I Webb; Michelle A Dunstone; Nicholas A Williamson; Jason D Price; Andrea de Kauwe; Weisan Chen; Aaron Oakley; Patrick Perlmutter; James McCluskey; Marie-Isabel Aguilar; Jamie Rossjohn; Anthony W Purcell
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

4.  Broad distribution of energetically important contacts across an extended protein interface.

Authors:  Lisa M Johnson; W Seth Horne; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2011-06-14       Impact factor: 15.419

5.  Backbone modification of a polypeptide drug alters duration of action in vivo.

Authors:  Ross W Cheloha; Akira Maeda; Thomas Dean; Thomas J Gardella; Samuel H Gellman
Journal:  Nat Biotechnol       Date:  2014-06-15       Impact factor: 54.908

6.  Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.

Authors:  Melissa D Boersma; Holly S Haase; Kimberly J Peterson-Kaufman; Erinna F Lee; Oliver B Clarke; Peter M Colman; Brian J Smith; W Seth Horne; W Douglas Fairlie; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2011-12-08       Impact factor: 15.419

Review 7.  Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; D James Nokes; Bradford D Gessner; Mukesh Dherani; Shabir A Madhi; Rosalyn J Singleton; Katherine L O'Brien; Anna Roca; Peter F Wright; Nigel Bruce; Aruna Chandran; Evropi Theodoratou; Agustinus Sutanto; Endang R Sedyaningsih; Mwanajuma Ngama; Patrick K Munywoki; Cissy Kartasasmita; Eric A F Simões; Igor Rudan; Martin W Weber; Harry Campbell
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

8.  Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization.

Authors:  Geoffrey A Weinberg; Caroline B Hall; Marika K Iwane; Katherine A Poehling; Kathryn M Edwards; Marie R Griffin; Mary Allen Staat; Aaron T Curns; Dean D Erdman; Peter G Szilagyi
Journal:  J Pediatr       Date:  2009-01-21       Impact factor: 4.406

9.  Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor.

Authors:  Victor K Outlaw; Jennifer T Lemke; Yun Zhu; Samuel H Gellman; Matteo Porotto; Anne Moscona
Journal:  J Am Chem Soc       Date:  2020-01-23       Impact factor: 15.419

10.  A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.

Authors:  Shuai Xia; Lei Yan; Wei Xu; Anurodh Shankar Agrawal; Abdullah Algaissi; Chien-Te K Tseng; Qian Wang; Lanying Du; Wenjie Tan; Ian A Wilson; Shibo Jiang; Bei Yang; Lu Lu
Journal:  Sci Adv       Date:  2019-04-10       Impact factor: 14.136

View more
  2 in total

Review 1.  Antivirals targeting paramyxovirus membrane fusion.

Authors:  Erik M Contreras; Isaac Abrrey Monreal; Martin Ruvalcaba; Victoria Ortega; Hector C Aguilar
Journal:  Curr Opin Virol       Date:  2021-09-27       Impact factor: 7.090

2.  Engineering Protease-Resistant Peptides to Inhibit Human Parainfluenza Viral Respiratory Infection.

Authors:  Victor K Outlaw; Ross W Cheloha; Eric M Jurgens; Francesca T Bovier; Yun Zhu; Dale F Kreitler; Olivia Harder; Stefan Niewiesk; Matteo Porotto; Samuel H Gellman; Anne Moscona
Journal:  J Am Chem Soc       Date:  2021-04-07       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.